Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin given as a bolus I.V. infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers (Q81038996)
Jump to navigation
Jump to search
scientific article published on 01 September 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin given as a bolus I.V. infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers |
scientific article published on 01 September 2007 |
Statements
Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin given as a bolus I.V. infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers (English)
Mark C Willingham
Raffit Hassan
Susie Bullock
Ahalya Premkumar
Robert J Kreitman
Hedy Kindler
1 September 2007